Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
04/2008
04/23/2008EP0763116B2 Recombinant viruses, preparation and use thereof in gene therapy
04/23/2008CN101164623A Compositions comprising viruses and methods for concentrating virus preparations
04/23/2008CN100383250C Method of expressing bird catching arachinid toxin I and its special carrier
04/23/2008CN100383161C Polypeptide for inhibiting gelatin enzyme A activity and its preparation method and application
04/22/2008US7361503 Sequences encoding hepatitis C virus glycoproteins
04/22/2008US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase
04/22/2008US7361496 Rescue of mumps virus from cDNA
04/22/2008US7361356 Gene expression in host cell of conformational epitopes; used as elements of diagnostic immunoassay procedures for papillomavirus infection
04/22/2008US7361352 Influenza immunogen and vaccine
04/22/2008CA2353417C Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
04/17/2008WO2008043805A1 Medium supplement for virus production
04/17/2008WO2007127264A3 Scalable production method for aav
04/17/2008WO2007084773A3 Enhanced production of infectious parvovirus vectors in insect cells
04/17/2008US20080090918 Macroporous gel; cooling aqueous solution of gel forming polymer and solvent at a temperature which freezes solvent
04/17/2008US20080090282 Use of cell surface displays in yeast cell catalyst supports
04/17/2008US20080090281 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
04/17/2008US20080089910 Attenuated Herpes Simplex Virus Type-2, Vectors Thereof and Immunogenic Compositions Thereof
04/17/2008US20080089909 nucleotide sequences encoding HIV-1 Clade A Gag, Pol (RT and Int), and Nef ("GRIN), HIV-1 Clade A Gag, RT and Nef ("GRN") or HIV-1 Clade A Env; generating an immune response against HIV-1
04/17/2008US20080089908 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
04/17/2008US20080089907 Modified vaccinia Ankara virus variant
04/17/2008US20080089864 Viral sequences for targeted replication in tumor cells
04/17/2008US20080089863 Non-Integrative And Non-Replicative Lentivirus , Preparation And Uses Thereof
04/17/2008CA2665603A1 Medium supplement for virus production
04/17/2008CA2665068A1 Methods for treating cancer with mva
04/16/2008EP1911836A1 Medium supplement for virus production
04/16/2008EP1910578A2 Methods and compositions for detecting bk virus
04/16/2008EP1910522A2 Caveolin-3 and in vitro culture of hepatitis c virus
04/16/2008EP1909849A2 Use of mutant herpes simplex virus-2 for cancer therapy
04/16/2008EP1660665B1 Chimaeric vector system
04/16/2008EP1477560B1 ALGA-ORIGIN PROMOTER and INTRON
04/16/2008CN101163714A Influenza nucleic acids, polypeptides, and uses thereof
04/16/2008CN100381565C Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant ibdv strains
04/15/2008US7358075 Infecting cells (serum free media), monitoring viability using flow cytometry open reading frame expression with flourescent antibody cell sorting; Postweaning multisystemic wasting syndrome; rapid, high yield
04/15/2008CA2082155C Swine pneumonia vaccine and method of preparation
04/10/2008WO2008040060A1 Vlp based vaccine delivery system
04/10/2008US20080085545 Compositions comprising viruses and methods for concentrating virus preparations
04/09/2008EP1908822A2 Infectious bursal disease virus mutants and vaccines
04/09/2008EP1908479A2 Anti-p53 Antibodies
04/09/2008EP1907610A2 Secretion of antibodies without signal peptides from bacteria
04/09/2008EP1907537A2 Paramyxoviridae virus preparations
04/09/2008EP1907536A1 Cell line for producing coronaviruses
04/09/2008EP1907535A2 Cdna construct of salmonidae alphavirus
04/09/2008EP1907534A1 Bacteriophage and their uses
04/09/2008EP1907414A2 Parechovirus, vaccines, medicaments and diagnostic kits
04/09/2008EP1228095B1 Modified gp100 and uses thereof
04/09/2008EP1186655B1 Packaging cell
04/09/2008CN100379865C Method and reagents for vaccination which generate a CD8 T cell immune response
04/09/2008CN100379853C Genetic constructs and compositions comprising RRE and CTE and uses thereof
04/09/2008CN100379451C 疫苗 Vaccine
04/08/2008USRE40233 Hepatitus B virus and Hepadnavirus mutant with a single mutation affecting the normal function of the DNA polymerase resulting in decreased sensitivity to a nucleoside analogue such as famciclovir, penciclovir and lamivudine; monitoring antiviral therapy
04/08/2008US7355033 Screening for West Nile Virus antiviral therapy
04/08/2008US7354756 Expression of nucleic acid produces polypeptide which spontaneously splices in host to yield a cyclized form; catalyzes formation of aminosuccinimide; useful in drug screening
04/08/2008US7354591 Poxvirus with targeted infection specificity
04/08/2008US7354190 Two-stage mixing system, apparatus, and method
04/08/2008CA2143104C Phagemids coexpressing a surface receptor and a surface heterologous protein
04/03/2008WO2008039357A2 Uncoupling of dna insert propagation and expression of protein for phage display
04/03/2008WO2008039136A1 Separation matrix for viral purification
04/03/2008WO2008039022A1 Human rotavirus and vaccine composition comprising same
04/03/2008WO2008038641A1 Method of proliferating hepatitis virus, hollow fiber for culturing hepatitis virus-infected cells and utilization of the same
04/03/2008WO2008037504A1 Interleukin-1 muteins linked to virus-like particles to treat il-1 associated diseases
04/03/2008CA2664418A1 Interleukin-1 muteins linked to virus-like particles to treat il-1 associated diseases
04/02/2008EP1905837A1 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
04/02/2008EP1905304A2 Treatment of neoplasms with viruses
04/02/2008EP1904627A2 Method for the preparation of prrs virus and proteins of and diagnostic test kits for detecting them
04/02/2008EP1904626A1 Chimeric empty viral-like particles derived from the infectious bursal disease virus (ibdv), process for their production and applications
04/02/2008EP1546313B1 Thermostable rna ligase from thermus phage
04/02/2008CN101155915A Virus purification using ultrafiltration
04/02/2008CN101153280A Method for purifying human papilloma virus advanced protein from prokaryote
04/02/2008CN100378216C 9M-negative EHV-mutants
04/01/2008US7351697 Tumor-specific vector for gene therapy
04/01/2008US7351570 Hepatitis d viral nucleotide sequences for use in diagnosis of hepatitis b infection
04/01/2008US7351533 Recombinant papilloma virions capable of forming conformational antigenic epitopes for use as therapeutic delivery systems; viricides; antitumor agents
04/01/2008US7351527 Isolated avirulent form of a carp virus, a double stranded DNA virus having a capsid with a icosahedron morphology and being of 90-110 nm in size and having 250,000 - 300,000 base pairs; causative agent of the disease affecting Cyprinus carpino; fish vaccines
04/01/2008US7351413 Stabilized HBc chimer particles as immunogens for chronic hepatitis
04/01/2008CA2305623C Porcine circovirus, vaccines, and diagnostic reagents
03/2008
03/27/2008WO2008034857A1 Pestivirus mutant for use in a vaccine
03/27/2008WO2008034476A1 Blood bag system and process for the inactivation of pathogens in platelet concentrates by use of the blood bag system
03/27/2008WO2008034388A1 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof
03/27/2008WO2008014251A3 Filter assembly for a reprocessor
03/27/2008US20080076904 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
03/27/2008US20080076824 Compounds That Inhibit Replication Of Human Immunodeficiency Virus
03/27/2008US20080076173 Adenovirus vectors containing cell status-specific response elements and methods of use thereof
03/27/2008US20080076115 Compositions and Methods for Detecting Severe Acute Respiratory Syndrome Coronavirus
03/27/2008US20080075740 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
03/27/2008US20080075739 Attenuated Salmonella SP12 Mutants as Antigen Carriers
03/27/2008US20080075737 inducing an immune response to an HIV antigen; genetic engineered polypeptide; inserted into cell; improves or restores the blood clotting time, blood disorders; gene therapy
03/27/2008US20080075736 Materials and methods for respiratory disease control in canines
03/27/2008CA2663443A1 Blood bag system and process for the inactivation of pathogens in platelet concentrates by use of the blood bag system
03/27/2008CA2663142A1 Pestivirus mutant for use in a vaccine
03/26/2008EP1902740A1 Blood bag system and process for the inactivation of pathogens in platelet concentrates by use of the blood bag system
03/26/2008EP1434789B1 Improved protein disaggregation and refolding using high pressure
03/26/2008EP0871482B1 Recombinant vesiculoviruses and their uses
03/26/2008CN101151363A Plant virus designated tomato torrado virus
03/26/2008CN101151272A Recombinant icosahedral virus like particle production in pseudomonads
03/26/2008CN101148661A Human papilloma virus 16 type coat protein virus-like particles, preparation method and use thereof
03/25/2008US7348410 Flea head, nerve cord, hindgut and malpighian tubule proteins
03/25/2008US7348314 Double-stranded ribonucleic acid
03/25/2008US7348177 Expression of HIV polypeptides and production of virus-like particles
03/25/2008US7348134 Cell-free system for translation and formation of HTLV lymphadenopathy associated viral coat proteins; viricides; drug screening
03/25/2008US7348014 Anticancer agents; gene therapy; trimers; host cells; genomes